Central histaminergic transmission modulates the expression of chronic nicotine withdrawal induced anxiety-like and somatic behavior in mice

The present study investigated the plausible modulatory role of central histaminergic transmission on the expression of nicotine withdrawal induced anxiety and somatic behavior in mice. Abrupt cessation of chronic nicotine (2 mg/kg, i.p. x 3/day) treatment for 12 days to mice, expressed increased anxiety in light & dark test and total abstinence (somatic) score at 24 h post nicotine withdrawal time. The somatic signs includes a composite score of all behaviors such as grooming, rearing, jumping, body shakes, forelimb tremors, head shakes, abdominal constrictions, scratching, empty mouth chewing or teeth chattering, genital licking, tail licking. Mice exhibited higher expression to nicotine withdrawal induced anxiety in light & dark test at 24 h post-nicotine withdrawal time on pre-treatment centrally (i.c.v) with histaminergic agents like histamine (0.1, 50 mu g/ mouse), histamine H-3 receptor inverse agonist, thioperamide (2, 10 mu g/mouse), histamine H-1 receptor agonist, FMPH (2, 6.5 mu g/mouse) or H-2 receptor agonist amthamine (0.1, 0.5 mu g/mouse) or intraperitoneally (i.p.) with histamine precursor, L-histidine (250, 500 mg/kg) as compared to control nicotine withdrawn animals. Furthermore, mice pre-treated with all these histaminergic agents except histamine H-1 receptor agonist, FMPH shows exacerbated expression to post-nicotine withdrawal induced total abstinence (somatic) score in mice. On the other hand, central injection of selective histamine H1 receptor antagonist, cetirizine (0.1 mu g/mouse, i.c.v.) or H-2 receptor antagonist, ranitidine (50 mu g/mouse, i.c.v) to mice 10 min before 24 h post-nicotine withdrawal time completely alleviated the expression of nicotine withdrawal induced anxiety and somatic behavior. Thus, it can be contemplated that the blockade of central histamine H-1 or H-2 receptor during the nicotine withdrawal phase could be a novel approach to mitigate the nicotine withdrawal associated anxiety-like manifestations. Contribution of endogenous histamine via H1 or H2 receptor stimulation in the nicotine withdrawal induced anxiety and somatic behavior is proposed.

Automated summary

The study investigated the role of central histaminergic transmission in modulating nicotine withdrawal-induced anxiety and somatic behaviors in mice. It was found that pre-treatment with histaminergic agents exacerbated anxiety and somatic behaviors in nicotine withdrawn mice, while blockade of histamine H1 or H2 receptors alleviated these symptoms.